Nexalin Technology (NXL) Return on Capital Employed (2022 - 2026)
Nexalin Technology's quarterly Return on Capital Employed came in at 253.22% in Q1 2026, up 3781.0% year-on-year from 6.52% in Q1 2025, and down 20.51% quarter-over-quarter from 210.12% in Q4 2025.
Nexalin Technology has reported Return on Capital Employed for 5 years, with the latest figure at 253.22% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 3781.0% year-over-year to 253.22%; the trailing twelve-month figure through Mar 2026 stood at 253.22% (up 3781.0% YoY), and the FY2025 full-year result was 236.92%, down 753.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 253.22%, down from 210.12% in the prior quarter.
- The five-year high for Return on Capital Employed was 30.84% in Q4 2022, with the low at 322.71% in Q2 2024.
- Average Return on Capital Employed over 5 years is 178.13%, with a median of 197.0% recorded in 2024.
- Year-over-year, Return on Capital Employed tumbled 26163 bps in 2024 and jumped 10448 bps in 2025.
- Tracing NXL's Return on Capital Employed over 5 years: stood at 30.84% in 2022, then plunged by 412 bps to 157.9% in 2023, then retreated by 17 bps to 184.93% in 2024, then dropped by 14 bps to 210.12% in 2025, then fell by 21 bps to 253.22% in 2026.
- The last three Return on Capital Employed figures came in at 253.22% (Q1 2026), 210.12% (Q4 2025), and 161.33% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -253.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253.22% |
| Dec 31, 2025 | -210.12% |
| Sep 30, 2025 | -161.33% |
| Jun 30, 2025 | -218.23% |
| Mar 31, 2025 | -291.03% |
| Dec 31, 2024 | -184.93% |
| Sep 30, 2024 | -209.07% |
| Jun 30, 2024 | -322.71% |
| Mar 31, 2024 | -219.77% |
| Dec 31, 2023 | -157.90% |
| Sep 30, 2023 | -132.81% |
| Jun 30, 2023 | -61.07% |
| Mar 31, 2023 | -40.78% |
| Dec 31, 2022 | -30.84% |